MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TICKU, M. K.
Right arrow Articles by BARKER, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TICKU, M. K.
Right arrow Articles by BARKER, J. L.

Molecular Pharmacology, Vol 17, 285-289, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Characterization of ggr-Aminobutyric Acid Receptor Binding in Cultured Brain Cells

MAHARAJ K. TICKU 1, ANN HUANG 2, and JEFFERY L. BARKER 2

1 Division of Molecular Pharmacology, Department of Pharmacology, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78284
2 Laboratory of Neurophysiology, NINCDS-NIH, Bethesda, Maryland 20205

The binding of the inhibitory neurotransmitter ggr-[3H]aminobutyric acid to its receptor sites was investigated in extensively washed membranes of primary brain cultured cells. Extensive washing of the brain cultured cells was necessary to eliminate the endogenous inhibitors of ggr-aminobutyric acid receptor binding. The binding of ggr-[3H]aminobutyric acid to cultured brain cells was specific, rapid, and saturable. Scatchard analysis of the binding data revealed the presence of two classes of sites. The high-affinity site had a KD1 of 9 nM and a Bmax1 of 380 fmol/mg protein, and the low-affinity site had a KD2 of 250 nM and a Bmax2 of 2400 fmol/mg protein. The specific binding was displaced by muscimol (IC50 = 0.005 µM), ggr-aminobutyric acid (IC50 = 0.025 µM), and (+)-bicuculline (IC50 = 4 µM). Specific binding was not inhibited by nipecotic acid, picrotoxin, or pentobarbital. On the basis of saturation, classes of sites, affinity constants, and ligand specificity, it appears that cultured brain cells have ggr-aminobutyric acid receptors which appear identical to those found in mammalian brain.

Note:
ACKNOWLEDGMENTS We thank Dr. M. Javors for reading the manuscript and Ms. M. Wilson for excellent secretarial help.

Submitted on August 27, 1979
Accepted on December 17, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics